NO913579L - Nye 3-aryl-4(3h)kinazolinoner og fremgangsmaate for deres fremstilling. - Google Patents

Nye 3-aryl-4(3h)kinazolinoner og fremgangsmaate for deres fremstilling.

Info

Publication number
NO913579L
NO913579L NO91913579A NO913579A NO913579L NO 913579 L NO913579 L NO 913579L NO 91913579 A NO91913579 A NO 91913579A NO 913579 A NO913579 A NO 913579A NO 913579 L NO913579 L NO 913579L
Authority
NO
Norway
Prior art keywords
chinazolinones
aryl
procedures
preparation
new
Prior art date
Application number
NO91913579A
Other languages
English (en)
Norwegian (no)
Other versions
NO913579D0 (no
Inventor
Ray Mccowan Jefferson
Jeff Thrasher Kenneth
Joseph Yu Melvin
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO913579D0 publication Critical patent/NO913579D0/no
Publication of NO913579L publication Critical patent/NO913579L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO91913579A 1990-09-13 1991-09-11 Nye 3-aryl-4(3h)kinazolinoner og fremgangsmaate for deres fremstilling. NO913579L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/581,943 US5075313A (en) 1990-09-13 1990-09-13 3-aryl-4(3H)quinazolinone CCK antagonists and pharmaceutical formulations thereof

Publications (2)

Publication Number Publication Date
NO913579D0 NO913579D0 (no) 1991-09-11
NO913579L true NO913579L (no) 1992-03-16

Family

ID=24327210

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91913579A NO913579L (no) 1990-09-13 1991-09-11 Nye 3-aryl-4(3h)kinazolinoner og fremgangsmaate for deres fremstilling.

Country Status (20)

Country Link
US (1) US5075313A (cs)
EP (1) EP0475755B1 (cs)
JP (1) JPH04247080A (cs)
KR (1) KR920006350A (cs)
CN (1) CN1059722A (cs)
AU (1) AU641043B2 (cs)
CA (1) CA2050994A1 (cs)
CZ (1) CZ279774B6 (cs)
DE (1) DE69113379T2 (cs)
ES (1) ES2078455T3 (cs)
FI (1) FI914262L (cs)
HU (1) HUT59128A (cs)
IE (1) IE913217A1 (cs)
IL (1) IL99402A0 (cs)
MX (1) MX9101035A (cs)
NO (1) NO913579L (cs)
NZ (1) NZ239712A (cs)
PT (1) PT98915A (cs)
YU (1) YU151691A (cs)
ZA (1) ZA917149B (cs)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340801A (en) * 1991-05-08 1994-08-23 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having cholecystokinin and gastrin antagonistic properties
US5204354A (en) * 1992-02-14 1993-04-20 Merck & Co., Inc. Substituted quinazolinones as neurotensin antagonists useful in the treatment of CNS disorders
UA27908C2 (uk) * 1992-06-05 2000-10-16 Мерк Шарп Енд Дом Лімітед Сульфатна сіль n,n-диметил-2-[5-(1,2,4-триазол-1ілметил)-1н-індол-3-іл]етиламіну та/або її сольвати, фармацевтична композиція на її основі, спосіб одержання фармацевтичної композиції і спосіб лікування
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
GB0031315D0 (en) * 2000-12-21 2001-02-07 Glaxo Group Ltd Indole derivatives
PL208110B1 (pl) 2001-01-26 2011-03-31 Schering Corp Kompozycja farmaceutyczna
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
DK1355644T3 (da) 2001-01-26 2006-10-23 Schering Corp Anvendelse af substituerede azetidinonforbindelser til behandling af sitosterolæmi
JP2005504091A (ja) 2001-09-21 2005-02-10 シェーリング　コーポレイション ステロール吸収阻害剤としてアゼチジノンを用いる黄色腫の処置
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
CA2504916A1 (en) 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
US7235543B2 (en) 2003-03-07 2007-06-26 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
WO2004081003A1 (en) 2003-03-07 2004-09-23 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholeterolemia
EP1606287B1 (en) 2003-03-07 2013-10-02 Merck Sharp & Dohme Corp. Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
US7348338B2 (en) * 2003-07-17 2008-03-25 Plexxikon, Inc. PPAR active compounds
US7202266B2 (en) 2003-07-17 2007-04-10 Plexxikon, Inc. PPAR active compounds
GB0319126D0 (en) * 2003-08-14 2003-09-17 Smithkline Beecham Corp Chemical compounds
WO2006060456A2 (en) * 2004-11-30 2006-06-08 Plexxikon, Inc. Indole derivatives for use as ppar ppar active compounds
EP1833787A2 (en) * 2004-11-30 2007-09-19 Plexxikon, Inc. Indole derivatives for use as ppar active compounds
CA2621275A1 (en) * 2005-09-07 2007-03-15 Plexxikon, Inc. 1 , 4 and 1 , 5-disubstituted indole derivatives for use as ppar active compounds
GT200600407A (es) * 2005-09-07 2007-04-10 Compuestos ppar activos
US7893260B2 (en) * 2005-11-04 2011-02-22 Hydra Biosciences, Inc. Substituted quinazolin-4-one compounds for antagonizing TRPV3 function
PE20090159A1 (es) * 2007-03-08 2009-02-21 Plexxikon Inc COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs
JP2023512664A (ja) 2020-01-29 2023-03-28 カマリ ファーマ リミテッド 皮膚障害の治療に使用するための化合物及び組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ192392A (en) * 1978-12-19 1983-02-15 M Ishikawa 3-(substituted (phenyl or pyridyl)) -3,4-dihydroquinazolin-4-ones
EP0336356A3 (en) * 1988-04-05 1991-09-25 Abbott Laboratories Derivatives of tryptophan as cck antagonists

Also Published As

Publication number Publication date
ZA917149B (en) 1992-05-27
US5075313A (en) 1991-12-24
DE69113379D1 (de) 1995-11-02
IE913217A1 (en) 1992-02-25
YU151691A (sh) 1994-01-20
CA2050994A1 (en) 1992-03-14
FI914262A7 (fi) 1992-03-14
PT98915A (pt) 1992-08-31
DE69113379T2 (de) 1996-03-21
NO913579D0 (no) 1991-09-11
CN1059722A (zh) 1992-03-25
EP0475755B1 (en) 1995-09-27
FI914262L (fi) 1992-03-14
EP0475755A1 (en) 1992-03-18
IL99402A0 (en) 1992-08-18
HU912921D0 (en) 1992-01-28
KR920006350A (ko) 1992-04-27
AU641043B2 (en) 1993-09-09
MX9101035A (es) 1992-05-04
JPH04247080A (ja) 1992-09-03
FI914262A0 (fi) 1991-09-10
HUT59128A (en) 1992-04-28
CS279991A3 (en) 1992-04-15
AU8382991A (en) 1992-03-19
ES2078455T3 (es) 1995-12-16
NZ239712A (en) 1993-06-25
CZ279774B6 (cs) 1995-06-14

Similar Documents

Publication Publication Date Title
NO913579L (no) Nye 3-aryl-4(3h)kinazolinoner og fremgangsmaate for deres fremstilling.
NO905354D0 (no) Nye glykopolypeptidderivater og fremgangsmaate for deres fremstilling.
NO873640D0 (no) Nye cefemforbindelser og fremgangsmaate til deres fremstilling.
NO891866L (no) Kromanderivater og fremgangsmaate for fremstilling derav.
NO875358L (no) 6-benzoksazinyl- og 6-benzotiazinyl-2,3,4,5-tetrahydropyridazin-3-oner og fremgangsmaate for deres fremstilling.
NO910003L (no) Vitamin e-derivater og fremgangsmaate for deres fremstilling.
NO870512L (no) 1,4-benzoksazinderivater og fremgangsmaate for deres fremstilling.
NO893196D0 (no) Hybrid-protein-c-sammensetninger og fremgangsmaater for deres fremstilling.
NO914288L (no) Nye 2-sakkarinylmetylarylkarboksylater og fremgangsmaater for deres fremstilling
NO893886L (no) Nye aminokinolinforbindelser og fremgangsmaate for deres fremstilling.
NO894624D0 (no) Kopolymerer og fremgangsmaate for deres fremstilling.
NO892494D0 (no) Kromanderivater og fremgangsmaate for fremstilling derav.
NO903096L (no) Termotrope semialifatiske kopolyesteramider og deres fremstilling.
NO894103L (no) Kromanderivater og fremgangsmaate for fremstilling derav.
NO911047L (no) Labdaner og fremgangsmaate for deres fremstilling.
NO883114L (no) 1h-pyrazol-1-alkanamider og fremgangsmaate for deres fremstilling.
NO900252L (no) Cefasporinderivater og fremgangsmaate for fremstilling derav.
NO900982L (no) Nye bronkospasmolytiske forbindelser og fremgangsmaater for fremstilling derav.
NO893565D0 (no) Etansulfonamidderivater og fremgangsmaate for deres fremstilling.
NO903484D0 (no) Substituerte pyrazinderivater og fremgangsmaate for deres fremstilling.
NO922608D0 (no) Nye cefalosporinforbindelser og fremgangsmaater til deres fremstilling
NO902094L (no) Nye dianhydridforbindelser og fremgangsmaate for deres fremstilling.
NO894697D0 (no) Penemderivater og fremgangsmaater for deres fremstilling.
NO922976D0 (no) Nye 2-sakkarinylmetylarylkarboksylater og fremgangsmaater for deres fremstilling
NO880691D0 (no) Nye forbindelser og fremgangsmaate for deres fremstilling.